Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Health Velocity Capital is a venture capital firm founded in 2016, with offices located in San Francisco, California, and Brentwood, Tennessee. The firm specializes in investing in healthcare technology companies, particularly in the digital health sector. Health Velocity Capital has a total AUM of approximately $485 million, which includes their oversubscribed $300 million Fund II and the $185 million Fund I. The firm has established a unique investment model that incorporates major health plans and systems as limited partners, providing not only capital but also strategic advantages to its portfolio companies.
Since its inception, Health Velocity Capital has focused on early to growth-stage investments, targeting innovations that enhance patient care and reduce healthcare costs. The firm has built a notable portfolio that includes companies like Zocdoc, Omada Health, and Wellframe, among others. Their approach emphasizes leveraging relationships with large healthcare organizations to facilitate access to distribution channels and pilot opportunities, which can significantly benefit their portfolio companies.
Health Velocity Capital has achieved several notable milestones, including successful exits such as Teladoc Health and Livongo Health. The firm has been recognized as one of the top healthcare investors, with its partners collectively bringing over 75 years of experience in the healthcare industry. This extensive background enables them to provide valuable insights and support to emerging companies in the healthcare technology space.
Health Velocity Capital invests exclusively in healthcare technology companies, focusing on sectors such as digital health, health IT, and healthcare services. The firm targets early to growth-stage companies, with investment stages ranging from pre-seed to growth equity. Check sizes typically range from $10 million to $50 million, allowing the firm to support companies at various points in their development.
The firm’s investment thesis centers on supporting innovations that improve patient outcomes and reduce costs within the healthcare system. Health Velocity Capital seeks to partner with companies that are creating new markets and have a history of financing healthcare industry 'firsts.' Their unique LP model, which includes major health plans and systems, provides portfolio companies with embedded distribution advantages and strategic validation, enhancing their chances of success.
Health Velocity Capital looks for founders who demonstrate a strong understanding of the healthcare landscape and possess a clear vision for their company's impact on patient care. The firm values innovative approaches that can lead to sustainable and consumer-friendly healthcare solutions. Their deal structure preferences often include co-investment opportunities with their LPs, further solidifying the strategic advantages available to their portfolio companies.
Health Velocity Capital has built a diverse portfolio of healthcare technology companies, with notable investments including:
Health Velocity Capital has also achieved notable exits, including:
Marty Felsenthal: Partner at Health Velocity Capital, Marty has extensive experience in the healthcare sector, having been instrumental in building leading healthcare companies. His background includes significant roles in various healthcare technology firms.
Bruce Crosby: Partner, Bruce brings a wealth of knowledge in healthcare investments and has a proven track record in identifying and supporting innovative healthcare solutions.
Saurabh Bhansali: Partner, Saurabh has a strong background in healthcare technology and has been involved in numerous successful investments in the sector.
Kristin Torres Mowat: Partner, Kristin specializes in healthcare services and has a deep understanding of the challenges and opportunities within the industry.
Grant Blevins: Partner, Grant has a background in healthcare operations and investment, contributing valuable insights to the firm's investment strategy.
Ken Goodhue: Chief Financial Officer, Ken oversees the financial operations of the firm, ensuring sound financial management and reporting.
Christian Pierce: Senior Associate, Christian supports the investment team with due diligence and market analysis.
Kai Jones: Senior Associate, Kai focuses on sourcing new investment opportunities and supporting portfolio companies.
Alex Egg-Krings: Director of Diligence, Alex leads the due diligence process for potential investments, ensuring thorough evaluation.
Julie Foster: Chief Administrative Officer, Julie manages the administrative functions of the firm, supporting operational efficiency.
Morgan Putty: Executive Assistant, Morgan provides support to the partners and assists with various administrative tasks.
To pitch to Health Velocity Capital, founders should visit their website at healthvelocitycapital.com. It is essential to include a comprehensive business plan, market analysis, and details on how the innovation addresses specific healthcare challenges. The firm prefers pitches that clearly outline the startup's vision, target market, and potential for scalability.
Health Velocity Capital values warm introductions, so leveraging connections within the healthcare industry or existing portfolio companies can enhance the chances of a successful pitch. Founders should expect a response time of several weeks, as the firm conducts thorough due diligence on potential investments.
In 2024, Health Velocity Capital achieved three successful partial or complete exits, with cash distributions to limited partners exceeding 100% of their fund size. This performance indicates strong realized returns for the firm.
Recently, Health Velocity Capital led a $30 million Series C investment in HealthJoy, a healthcare consumer benefits platform. This investment aligns with the firm's focus on supporting innovations that enhance patient care.
The firm has been recognized in various publications, including being named among the '17 Digital Health Investors You Need to Know in 2025' by Accretive Edge and 'Top Healthcare Investors of 2025' by GrowthCap.
What are Health Velocity Capital's investment criteria?
Health Velocity Capital focuses on early to growth-stage healthcare technology companies, particularly in sectors such as digital health, health IT, and healthcare services. They seek innovations that improve patient outcomes and reduce costs.
How can I apply or pitch to Health Velocity Capital?
Founders can pitch their ideas through the firm's website at healthvelocitycapital.com. It is advisable to include a clear business plan, market analysis, and details on how the innovation addresses specific healthcare challenges.
What makes Health Velocity Capital different from other investors?
The firm has a unique LP model that includes major health plans and systems, providing portfolio companies with embedded distribution advantages and strategic validation. This structure enhances the potential for successful market entry and growth.
What is the geographic scope of Health Velocity Capital's investments?
Health Velocity Capital primarily invests in companies based in the United States, focusing on innovations that can significantly impact the U.S. healthcare system.
What is Health Velocity Capital's post-investment involvement like?
The firm actively supports its portfolio companies through its extensive network of health plans and systems, facilitating access to distribution channels and pilot opportunities. Partners often provide mentorship and operational support.
What are the typical fund sizes and check sizes for Health Velocity Capital?
Health Velocity Capital's Fund I was $185 million, while Fund II is $300 million. Check sizes typically range from $10 million to $50 million, depending on the stage of the company.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.